Radiopaque ePTFE medical devices

• US 8,088,158 B2
• Filed: 12/20/2002
• Issued: 01/03/2012
• Est. Priority Date: 12/20/2002
• Status: Expired due to Fees

• Current Assignee: Lifeshield Sciences LLC (Acacia Research Corporation)
• Original Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Inventors: Brodeur, Christopher Brian
• Primary Examiner(s): Isabelle, David
• Assistant Examiner(s): IWAMAYE, ANDREW MICHAEL
• Application Number:
  US10/324,367
• Publication Number:
  US 20040122509A1
• Time in Patent Office: 3,301 Days
• Field of Search: 623/1.1, 623/11.11, 623/12, 623/1.13, 623/1.34, 623/1.45, 623 149- 154, 606191-198, 600/36
• US Class Current: 623/1.34
• CPC Class Codes: A61F 2/07 Stent-grafts
• CPC Class Codes: A61F 2/90 characterised by a net-like or mesh-like structure
• CPC Class Codes: A61F 2002/072 Encapsulated stents, e.g. wire or whole stent embedded in lining
• CPC Class Codes: A61F 2002/075 the stent being loosely attached to the graft material, e.g. by stitching
• CPC Class Codes: A61F 2250/0098 radio-opaque, e.g. radio-opaque markers

Abstract

A radiopaque implantable prosthesis including a polymeric prosthesis made from ePTFE having a node and fibril structure and a radiopaque filler integral with at least a portion of the node and fibril structure of the ePTFE. A method of making the prosthesis is also provided.

Claims

1. A radiopaque implantable stent-graft, comprising:

a polymeric prosthesis having inner and outer surfaces and an extruded tubular shape, said polymeric prosthesis being made from ePTFE having a node and fibril structure with nodes and fibrils; and

a radiopaque filler fully integral with said nodes and fibrils, wherein said radiopaque filler is present in amounts sufficient to be fluorometrically detectable, avoid interfering with angiography procedures and still maintain structural integrity of the polymeric prosthesis, said amounts ranging from about 5% to about 20% by weight, said radiopaque filler being distributed therein to form radiotranslucent portions of said polymeric prosthesis,

wherein said polymeric prosthesis is free of said radiopaque filler on the inner and outer surfaces; and

a stent disposed over the extruded tubular shape.

2. The radiopaque implantable stent-graft according to claim 1, wherein said radiopaque filler is uniformly distributed in said polymeric prosthesis.

3. The radiopaque implantable stent-graft according to claim 1, wherein said radiopaque filler is particles, said particles have an average diameter of from about 0.05 microns to about 2 microns.

4. The radiopaque implantable stent-graft according to claim 1, wherein said radiopaque filler is in the form of particles, said particles have an average diameter of from about 0.05 microns to about 0.5 microns.

5. The radiopaque implantable stent-graft according to claim 4, wherein said particles have an average diameter of from about 0.05 microns to about 0.1 microns.

6. The radiopaque implantable stent-graft according to claim 1, wherein said radiopaque filler is a material formed with particles comprising at least one member selected from the group consisting of platinum, stainless steel, silver, barium, bismuth, iridium, rhenium, osmium, palladium, gold, and oxides thereof.

7. The radiopaque implantable stent-graft according to claim 1, wherein a portion of the polymeric prosthesis that is rendered radiopaque has a uniform characteristic with said radiopaque filler being evenly distributed throughout said portion.

8. The radiopaque implantable stent-graft according to claim 1, wherein the stent-graft is bound by edges provided at distal ends of said extruded tubular shape having a structural integrity to be implantable into a patient'"'"'s body.

9. The radiopaque implantable stent-graft of claim 1 wherein said radiopaque filler is a plurality of radiopaque particles.